| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2017-06-12 | RiboMABs®(mRNA-encoded antibody drugs) | preclinical | BioNTech (Germany) | ||
| 2017-06-12 | ADS-5102 (amantadine hydrochloride) | levodopa-induced dyskinesia (LID) in Parkinson's disease (PD) patients | 2-3 | Adamas Pharmaceuticals (USA - CA) | Neurodegenerative diseases - Rare diseases |
| 2017-06-11 | PQ912 | Alzheimer’s Disease | 2a | Probiodrug (Germany) | Neurodegenerative diseases |
| 2017-06-10 | MYL-1501D (biosimilar version of insulin glargin) | type 1 diabetes, type 2 diabetes | 3 | Mylan (USA - PA) Biocon (India) | Metabolic diseases |
| 2017-06-10 | ZGN-1061 | patients with type 2 diabetes who are overweight or obese | 1 | Zafgen (USA - MA) | Metabolic diseases |
| 2017-06-10 | ertugliflozin | type 2 diabetes | 3 | Merck&Co (USA - NJ) - Pfizer (USA - NY) | Metabolic diseases |
| 2017-06-10 | Soliqua®/iGlarLixi® (single injection Lyxumia®(lixisenatide) /Lantus® (insuline glargine) combination product | diabetes | 3 | Sanofi (France) Zealand Pharma (Denmark) | Metabolic diseases |
| 2017-06-09 | Orkambi® (lumacaftor in combination with ivacaftor ) | cystic fibrosis | 3 | Vertex Pharmaceuticals (USA - MA) | Rare diseases - Genetic diseases |
| 2017-06-09 | Xilonix™ | advanced colorectal cancer | 3 | XBiotech (USA - TX) | Cancer - Oncology |
| 2017-06-09 | Orkambi® (lumacaftor in combination with ivacaftor ) | children with cystic fibrosis (CF) ages 6 through 11 who have two copies of the F508del mutation | 3 | Vertex Pharmaceuticals (USA - MA) | Rare diseases - Genetic diseases |
| 2017-06-09 | Xtandi® (enzalutamide) | non metastatic castration-resistant prostate cancer | 3 | Medivation (USA - CA), now Pfizer (USA - NY) Astellas (Japan) | Cancer - Oncology |
| 2017-06-08 | ALKS 3831 | schizophrenia | 3 | Alkermes (Ireland) | CNS diseases - Mental diseases |
| 2017-06-08 | AMG 334 (erenumab) | migraine | 3 | Amgen (USA - CA) Novartis (Switzerland) | CNS diseases |
| 2017-06-08 | AMG 334 (erenumab) | migraine | 3 | Amgen (USA - CA) Novartis (Switzerland) | CNS diseases |
| 2017-06-08 | SENS-401 | inner ear lesions | 1 | Sensorion (France) | Otorhinolaryngology |
| 2017-06-08 | VGX-3100 | cervical dysplasia caused by human papillomavirus (HPV) | 3 | Inovio Pharmaceuticals (USA - PA) | Infectious diseases - Women health - Cancer - Oncology |
| 2017-06-07 | BioChaperone® Combo 75/25 | type 2 diabetes | 1b | Adocia (France) | Metabolic diseases |
| 2017-06-07 | CTL019 - tisagenlecleucel-T | diffuse large B-cell lymphoma (DLBCL) | 2 | Novartis (Switzerland) | Cancer - Oncology |
| 2017-06-07 | alidornase alfa AIR DNase™ (PRX-110) | cystic fibrosis | 2 | Protalix BioTherapeutics (Israel) | Rare diseases - Genetic diseases |
| 2017-06-06 | solriamfetol - JZP-110 (formerly known as ADX-N05) | excessive sleepiness | 3 | Jazz Pharmaceuticals (Ireland) | Rare diseases |
